Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 8, Number 3—March 2002

Synopsis

Human Campylobacteriosis in Developing Countries1

Akitoye O. Coker*Comments to Author , Raphael D. Isokpehi*, Bolaji N. Thomas*, Kehinde O. Amisu*, and C. Larry Obi†
Author affiliations: *University of Lagos, Idi-Araba, Lagos, Nigeria; †University of Venda for Science and Technology, Thohoyandon, South Africa;

Main Article

Table 4

Trends in Resistance to Ciprofloxacin by Campylobacter jejuni in selected developed countries up to year 2000

Country Period Resistance strains (%) Ref.
Initial Year 2000
Freiburg, Germany 1992-2000 22 32 41
Styria, Austria 1996-2000 25.2 40.2 42
England and Wales, UK 1993-2000 10 14.8 44
Philadelphia, USA 1995-2000 <10 36 45
Oslo, Norway 1988-2000 6.1 36 46

Main Article

1 Portions of this review were presented at the World Health Organization Consultation on the Increasing Incidence of Campylobacteriosis in Humans, Copenhagen, Denmark, November 1-25, 2000. In addition, relevant emerging information from the 11th International Workshop on Campylobacter, Helicobacter and Related Organisms, held in Freiburg, Germany, September 1-5, 2001, are included.

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO